Spinal injection combo targets tough lung cancer spread
NCT ID NCT06663306
First seen Mar 11, 2026 · Last updated May 29, 2026 · Updated 13 times
Summary
This early-phase trial tests whether injecting two drugs (pemetrexed and bevacizumab) directly into the spinal fluid can help people with a specific type of lung cancer that has spread to the lining of the brain and spinal cord. About 19 adults whose cancer has not responded to standard treatments will receive the therapy. The main goal is to check safety and side effects, while also tracking how long participants live.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.